Herein, light-responsive nanocarriers based on hollow mesoporous silica (HMS) nanoparticles modified with spiropyran-containing light-responsive copolymer (PRMS-FA) were fabricated via a simple self-assembly process. HMS modified with long-chain hydrocarbon octadecyltrimethoxysilane was an ideal base material owing to its good biocompatibility and drug capability. The spiropyran-containing amphiphilic copolymer could shift its hydrophilic–hydrophobic balance to become hydrophilic upon UV (λ = 365 nm) irradiation and then break away from the hydrophobic surface of the HMS core, followed by the uncaging and release of the pre-loaded anticancer drug. Simultaneously, the fluorescence resonance energy transfer (FRET) process based on the structural transformation of PRMS-FA was observed, which could act as a real-time monitor for the light-controlled drug release. Our model experiments in vitro tested and verified that this composite nanocarrier has good biocompatibility, active tumour targeting to the folate receptor over-expressed in tumour cells, is non-toxic to normal cells and that light-controlled drug release with real-time monitoring can be achieved.
本文通过简单的自组装工艺,制备了基于含螺
吡喃光响应共聚物(PRMS-FA)修饰的中空介孔
二氧化硅(
HMS)纳米颗粒的光响应纳米载体。长链碳氢化合物
十八烷基
三甲氧基硅烷修饰的
HMS 具有良好的
生物相容性和药物功能,是一种理想的基础材料。在紫外线(λ = 365 nm)照射下,含有螺
吡喃的两亲共聚物可改变其亲
水-疏
水平衡,变得亲
水,然后脱离
HMS 内核的疏
水表面,释放出预载的抗癌药物。与此同时,我们还观察到了基于 PRMS-FA 结构转变的荧光共振能量转移(FRET)过程,该过程可作为光控药物释放的实时监测器。我们的体外模型实验测试并验证了这种复合纳米载体具有良好的
生物相容性、对肿瘤细胞中过度表达的叶酸受体具有积极的肿瘤靶向性、对正常细胞无毒,并且可以实现实时监测的光控药物释放。